AbbVie to Buy Apogee Therapeutics for $10.9 Billion

Posted on 06/22/2026
|

Bloomberg Intelligence's Sam Fazeli discusses AbbVie's $10.9 billion acquisition of Apogee Therapeutics. The deal enhances AbbVie's presence in dermatology by adding treatments for atopic dermatitis, commonly known as eczema, to its portfolio. He speaks on "Bloomberg Open Interest."

--------

More on Bloomberg Television and Markets



Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9

Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more.



Connect with Bloomberg Television on:

X: https://twitter.com/BloombergTV

Facebook: https://www.facebook.com/BloombergTelevision

Instagram: https://www.instagram.com/bloombergtv/



Connect with Bloomberg Business on:

X: https://twitter.com/business

Facebook: https://www.facebook.com/bloombergbusiness

Instagram: https://www.instagram.com/bloombergbusiness/

TikTok: https://www.tiktok.com/@bloombergbusiness?lang=en

Reddit: https://www.reddit.com/r/bloomberg/

LinkedIn: https://www.linkedin.com/company/bloomberg-news/



More from Bloomberg:

Bloomberg Radio: https://twitter.com/BloombergRadio



Bloomberg Surveillance: https://twitter.com/bsurveillance

Bloomberg Politics: https://twitter.com/bpolitics

Bloomberg Originals: https://twitter.com/bbgoriginals



Watch more on YouTube:

Bloomberg Technology: https://www.youtube.com/@BloombergTechnology

Bloomberg Originals: https://www.youtube.com/@business

Bloomberg Quicktake: https://www.youtube.com/@BloombergQuicktake

Bloomberg Espanol: https://www.youtube.com/@bloomberg_espanol

Bloomberg Podcasts: https://www.youtube.com/@BloombergPodcasts